Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430000, China
NCT Number: NCT05386940
Acute kidney injury (AKI) is one of the most frequent major complications in patients undergoing cardiac surgery. CSA-AKI is independently related to increased perioperative mortality, increased hospital and ICU length of stay as well as heath care expenditure. Identification of relevant biomarkers may lead to early diagnosis and improve patient outcomes and health care costs. The pathophysiology of CSA-AKI is complex and ischemia-reperfusion injury is one of the important factors. Recently, it has been shown that Protein kinase N1 (PKN1) is associated with ischemia-reperfusion injury. In this study, relationship between PKN1 with the risk of CSA-AKI was analyzed and the predictive value of elevated level of PKN1 for early prediction of CSA-AKI was further evaluated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Wuhan, Hubei, 430000, China
Acute kidney injury (AKI) is one of the most frequent major complications in patients undergoing cardiac surgery. The incidence of cardiac surgery-associated AKI (CSA-AKI) varies from 5% to 42% and is the second leading cause of AKI (after sepsis) in the intensive care unit (ICU). CSA-AKI is independently related to increased perioperative mortality, increased hospital and ICU length of stay as well as heath care expenditure. Early detection of CSA-AKI could improve patient outcomes and health care costs through targeted interventions. Thus, identification of relevant biomarkers may lead to early diagnosis. The pathophysiology of CSA-AKI is complex and ischemia-reperfusion injury is one of the important factors. Recently, it has been shown that Protein kinase N1 (PKN1) is associated with ischemia-reperfusion injury. Nowadays, little is known about relationship between PKN1 and CSA-AKI. In this study, relationship between PKN1 with the risk of CSA-AKI was analyzed and the predictive value of elevated level of PKN1 for early prediction of CSA-AKI was further evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
different PKN1 level after on-pump cardiac surgery
Time frame: 1 Week
the development of CSA-AKI
Time frame: 1 Week
AKI stage 1,stage 2,stage 3
Time frame: 1 Week
Reflect kidney function
Time frame: 1 Week
Reflect kidney function
Time frame: up to 28 days
Reflect patient prognosis
Time frame: up to 28 days
Reflect patient prognosis
Zhongnan Hospital
Other
Protein Kinase N1 Level Predicts Acute Kidney Injury in Patients Undergoing Cardiac Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06871826
Acute Kidney Injury, Extracorporeal Circulation; Complications
Wuhan, Hubei, China
View Trial DetailsNCT06453161
Acute Kidney Injury, Cardiac
Bron, Rhône, France
View Trial DetailsNCT03513718
Acute Kidney Injury, CBP
Lausanne, Canton of Vaud, Switzerland
View Trial DetailsNCT04341974
Acute Kidney Injury, Cronich Kidney Disease
Florence, Italy
View Trial Details